- Inhibitors
- Antibodies
- Compound Libraries
- New Products
- Contact Us
research use only
Cat.No.S2930
| Cell Lines | Assay Type | Concentration | Incubation Time | Formulation | Activity Description | PMID |
|---|---|---|---|---|---|---|
| Saos-2 cells | Function assay | 10 μM | 48 h | Binding affinity to p53 transfected in human Saos-2 cells harboring pLV-53 assessed as reduction of p53 protein in mitochondria at 10 uM after 48 hrs | ||
| human T293 cells | Function assay | 15 μM | 48 h | Binding affinity to p53 transfected in human T293 cells assessed as reduction in p53 bound-Bcl-2 at 15 uM after 48 hrs | ||
| WI38 cells | Function assay | 10 μM | 24 h | Inhibition of p53-mediated apoptosis in human WI38 cells assessed as cell survival at 10 uM after 24 hrs by methylene blue assay | ||
| Click to View More Cell Line Experimental Data | ||||||
|
In vitro |
DMSO
: 36 mg/mL
(198.66 mM)
Ethanol : 36 mg/mL Water : Insoluble |
|
In vivo |
|||||
Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)
Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)
Calculation results:
Working concentration: mg/ml;
Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )
Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.
Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.
Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.
| Molecular Weight | 181.21 | Formula | C8H7NO2S |
Storage (From the date of receipt) | |
|---|---|---|---|---|---|
| CAS No. | 64984-31-2 | Download SDF | Storage of Stock Solutions |
|
|
| Synonyms | NSC 303580, PFTμ, 2-Phenylethynesulfonamide | Smiles | C1=CC=C(C=C1)C#CS(=O)(=O)N | ||
| Targets/IC50/Ki |
p53
|
|---|---|
| In vitro |
Pifithrin-μ interferes with p53 binding to mitochondria and inhibits rapid p53-dependent apoptosis of primary cell cultures of mouse thymocytes in response to gamma radiation. This compound, as an inhibitor of inducible HSP70, significantly inhibited cell viability with IC50 values ranging from 2.5 to 12.7 μM in acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL) cell lines, as well as in primary AML blasts. It is also highly active in primary AML blasts with a median IC50 of 8.9 μ M(range 5.7-37.2 μ M) and induces apoptosis and cell cycle arrest in a dose-dependent fashion. In addition, this chemical also increases the active form of caspase-3 and reduces AKT and ERK1/2 in NALM-6 cells. It increases Annexin V(+) cells in both caspase-dependent and -independent manners and promotes TRAIL-induced apoptosis and arrested cancer cell growth.
|
| In vivo |
Pifithrin-μ (40 mg/kg, ip) produces protective effect from p53-dependent apoptosis in C57B1/6J mice of 8 or 9 Gy of total body gamma radiation. In a xenograft mouse model, this compound significantly enhances the inhibition of TRAIL on MiaPaca-2 tumor growth.
|
References |
|
| Methods | Biomarkers | Images | PMID |
|---|---|---|---|
| Western blot | p-LIMK / RhoA / p-4EBP1 c-Myc / Cyclin D1 / p21(WAF1/Cip) |
|
20386595 |
| Immunofluorescence | p53 |
|
26958937 |
| Growth inhibition assay | Cell viability |
|
24244355 |
Tel: +1-832-582-8158 Ext:3
If you have any other enquiries, please leave a message.